Canada· CA-DIN-02532379

GLYCOPYRROLATE INJECTION USP

A glycopyrronium bromid product containing glycopyrrolate, registered in Canada by JAMP PHARMA CORPORATION. The same ATC class is registered in 12 of our 19 countries.

ATC A03AB02

Checked against Health Canada Drug Product Database (Canada) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about glycopyrrolateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Glycopyrronium bromid is registered in 12 of 19 countries.

Countries holding a registration under ATC A03AB02 (glycopyrronium bromid), each read from that country’s own register.

This record: Canada, from Health Canada Drug Product Database (Canada)
7 of them publish a price we can compare per daily dose

Search glycopyrronium bromid products by name

Glycopyrronium bromid · ATC A03AB02

12 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)

Active substance: GLYCOPYRROLATE
Manufacturer: JAMP PHARMA CORPORATION
Country: Canada (CA)
ATC code: A03AB02
ATC class: Glycopyrronium bromid
Defined daily dose: 3 mg, O
Reimbursed: Not published by this register
Source register: Health Canada Drug Product Database (Canada)
Last checked: October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Glycopyrronium bromid in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glycopyrronium bromid products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Axhidrox, Glycopyrroniumbromid Accord
Belgium · Axhidroks, Robinul
Bulgaria · Axhidrox, Амидил Амихалер
Cyprus · Glycopyrronium Bromide Accord, Robinul
Czechia · Amidil Amihaler, Axhidrox
Germany · Axhidrox, Glycopyrronium Axiromed
Denmark · Axhidrox, Glycopirronium Medical Valley
Estonia · Axhidrox
Finland · Axhidrox, Glykopyrroniumbromidi Accord
France · Glycopyrronium Biogaran, Glycopyrronium Wolff
United Kingdom (Northern Ireland) · Assicco, Glycopyrrolate Mercury Pharmaceuticals
Greece · Axhidrox, Glycopyrronium Verisfield
Croatia · Axhidrox
Hungary · Axhidrox, Rybrila
Ireland · Axhidrox, Glycopyrronium Bromide Ethypharm
Iceland · Seebri Breezhaler, Sialanar
Italy · Axhidrox, Glicopirronio Bromuro Accord
Liechtenstein · Seebri Breezhaler, Sialanar
Lithuania · Akshidroz
Luxembourg · Axhidroks, Robinul
Latvia · Axhidrox
Malta · Glycopyrronium Morningside
Netherlands · Axhidrox, Dusmyla
Norway · Axhidrox, Glycopirronium Medical Valley
Poland · Amidil Amihaler, Axhidrox
Portugal · Glicopirrónio Axidrox
Romania · Axhidrox
Sweden · Axhidrox, Glycopirronium Medical Valley
Slovenia · Axhidrox
Slovakia · Axhidrox

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b6528174-686c-4030-9f7b-952cca8176b3
GET /v1/drugs/b6528174-686c-4030-9f7b-952cca8176b3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02532379",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "INTRAMUSCULAR",
    "INTRAVENOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "A03AB02",
  "schedule": [
    "Ethical"
  ],
  "drug_code": "102141",
  "strengths": [
    "0.2 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "GLYCOPYRROLATE"
  ],
  "product_categorization": null
}

API reference MCP server Plans

See everything about glycopyrronium bromid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console